Neurological Adverse Reactions to SARS-CoV-2 Vaccines

Abstract

SARS-CoV-2 vaccines are not free of side effects and most commonly affect the central or peripheral nervous system (CNS, PNS). This narrative review aims to summarise recent advances in the nature, frequency, management, and outcome of neurological side effects from SARS-CoV-2 vaccines. CNS disorders triggered by SARS-CoV-2 vaccines include headache, cerebro-vascular disorders (venous sinus thrombosis [VST], ischemic stroke, intracerebral hemorrhage, subarachnoid bleeding, reversible, cerebral vasoconstriction syndrome, vasculitis, pituitary apoplexy, Susac syndrome), inflammatory diseases (encephalitis, meningitis, demyelinating disorders, transverse myelitis), epilepsy, and a number of other rarely reported CNS conditions. PNS disorders related to SARS-CoV-2 vaccines include neuropathy of cranial nerves, mono-/polyradiculitis (Guillain-Barre syndrome [GBS]), Parsonage-Turner syndrome (plexitis), small fiber neuropathy, myasthenia, myositis/dermatomyositis, rhabdomyolysis, and a number of other conditions. The most common neurological side effects are facial palsy, intracerebral hemorrhage, VST, and GBS. The underlying pathophysiology is poorly understood, but several speculations have been generated to explain the development of CNS/PNS disease after SARS-CoV-2 vaccination. In conclusion, neurological side effects develop with any type of SARS-CoV-2 vaccine and are diverse, can be serious and even fatal, and should be taken seriously to initiate early treatment and improve outcome and avoid fatalities. KEY WORDS: Side effects; COVID-19 vaccination; Neurological; Brain; Nerves."venous sinus thrombosis", "multiple sclerosis", "acute disseminated encephalomyelitis", "seizure", "Guillain Barre syndrome", "Parsonage Turner syndrome", "myositis", and "myasthenia". In addition, reference lists were searched for additional articles that matched the search criteria. Neurological COVID Vaccination Complications 223Table 1. Most common marketed anti-SARS-CoV-2 vaccines Company Generic name Brand name Ⓡ Technology Number of dosages Biontech Pfizer BNT162b2 Comirnaty m-RNA Two/booster Moderna m-RNA1273 Spikevax m-RNA Two/booster Astra Zeneca ChAdOx1-S nCoV-19 Vaxzevira Viral vector Two/booster Curevac CVnCoV Zorecimeran m-RNA Two Novavax NVX-Cov2373 Novaxovid Protein subunit Two Johnson & Johnson Ad26.COV.2S Jcovden Viral vector One Sinovac CoronaVac CoronaVac Viral vector Two/booster Valneva VLA2001 COVID-19 vaccine Viral vector Two/booster Sinopharm COVID 2019 vaccine BIBP Viral vector Two/booster Gam-Covid-Vac Sputnik-V Gam-Covid-Vac Viral vector Two Bharat Biotech BBV152 Covaxin Viral vector Two/booster CanSino Biologics Ad5-nCoV Convidecia Viral vector Single Sinopharm BBIBP32-CorV Covilo Viral vector Two booster Sanofi Pasteur VidPrevtyn beta VidPrevtyn beta Protein subunit OneOriginal articles and reviews published between 1966 and December 2022 were included. Abstracts, proceedings, and editorials were excluded from data analysis. The review does not claim to be complete, since the number of words and references was...

The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects

“…One group that focused on PASC in the context of the elderly showed that an approximated 30% of patients over the age of 65 developed it (190), while another study showed that Long COVID symptoms were more severe in elderly patients (191), supporting data gathered by the US Census Bureau, though it should be noted that the elderly do not have the highest reported incidence rate of post-COVID symptoms following infection (192). Within the context of vaccination alone, the development of Long COVID has not been extensively addressed, though neuropathic symptoms have been reported, albeit at a lesser occurrence rate than primary infection without vaccination (193)(194)(195). While evidence suggests that those vaccinated before infection have protection against Long COVID (196), symptom development after vaccination alone is a phenomenon that is not understood and warrants preclinical investigation, particularly in the context of the elderly.…”

Characteristics of Persistent Symptoms Manifested after SARS-CoV-2 Vaccination: An Observational Retrospective Study in a Specialized Clinic for Vaccination-Related Adverse Events

“…Fatal reactions including thrombotic thrombocytopenia, myocarditis/pericarditis, rhabdomyolysis, and anaphylaxis were noted in a previous review article [12]. Both central and peripheral nervous systems have also been reported to be involved in adverse reactions to mRNA vaccines [13]. Possible central nervous system disorders include venous sinus thrombosis, ischemic stroke, intracerebral hemorrhage, subarachnoid bleeding, reversible cerebral vasoconstriction syndrome, vasculitis, pituitary apoplexy, Susac syndrome, encephalitis, meningitis, demyelinating disorders, transverse myelitis, and epilepsy [13].…”

Clinical characteristics of motor functional neurological disorder manifesting as limb weakness after vaccination against coronavirus disease 2019: A case series

“…The side effects of COVID-19 vaccines include local injection site reactions, fever, fatigue, and various neurological conditions (such as headache, venous sinus thrombosis, encephalitis, epilepsy, Guillain-Barre syndrome, facial palsy, myositis, and dermatomyositis). [ [8] , [9] , [10] , [11] ]…”